BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 389758)

  • 1. Prostacyclin, thromboxane A2 interactions in haemostasis and thrombosis.
    Moncada S; Amezcua JL
    Haemostasis; 1979; 8(3-5):252-65. PubMed ID: 389758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interrelationships between prostacyclin and thromboxane A2.
    Moncada S; Vane JR
    Ciba Found Symp; 1980; 78():165-83. PubMed ID: 6258879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostacyclin and thromboxane A2 release in isolated rat lungs.
    Korbut R; Boyd J; Eling T
    Prostaglandins; 1982 Jan; 23(1):67-75. PubMed ID: 7038777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drugs that modulate prostaglandins, prostacyclin, and thromboxane A2.
    Moncada S; Vane JR
    Drug Ther; 1982; ():37-65. PubMed ID: 7049651
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prostacyclin and thromboxane in thrombosing atherosclerotic diseases].
    Viinikka L
    Duodecim; 1981; 97(13):925-7. PubMed ID: 7032876
    [No Abstract]   [Full Text] [Related]  

  • 6. The platelet-perfused in-vitro heart: an alternative model for studying the role of endogenous prostacyclin and thromboxane in control of coronary perfusion.
    Köhler P; Schrör K
    Basic Res Cardiol; 1981; 76(5):463-7. PubMed ID: 7030300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Respiratory movements alter the generation of prostacyclin and thromboxane A2 in isolated rat lungs: the influence of arachidonic acid-pathway inhibitors on the ratio between pulmonary prostacyclin and thromboxane A2.
    Korbut R; Boyd J; Eling T
    Prostaglandins; 1981 Mar; 21(3):491-503. PubMed ID: 7015418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prostacyclin--thromboxane A2 balance: pathophysiological and therapeutic implications.
    Bunting S; Moncada S; Vane JR
    Br Med Bull; 1983 Jul; 39(3):271-6. PubMed ID: 6354352
    [No Abstract]   [Full Text] [Related]  

  • 9. Platelet function and biosynthesis of prostacyclin and thromboxane A2 in whole blood after aspirin administration in human subjects.
    Mehta JL; Mehta P; Lopez L; Ostrowski N; Aguila E
    J Am Coll Cardiol; 1984 Oct; 4(4):806-11. PubMed ID: 6384329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thromboxane A2, prostacyclin and aspirin: effects on vascular tone and platelet aggregation.
    Smith JB; Araki H; Lefer AM
    Circulation; 1980 Dec; 62(6 Pt 2):V19-25. PubMed ID: 7002350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandins, platelets, and atherosclerosis.
    Gryglewski RJ
    CRC Crit Rev Biochem; 1980; 7(4):291-338. PubMed ID: 6771102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostacyclin, thromboxane and prostaglandin F2 alpha in suction blister fluid of human skin: effect of systemic aspirin and local glucocorticosteroid treatment.
    Oikarinen A; Viinikka L; Rytsälä H; Kiistala U; Ylikorkala O
    Life Sci; 1981 Jul; 29(4):391-6. PubMed ID: 7024698
    [No Abstract]   [Full Text] [Related]  

  • 13. Differential inhibition by low-dose aspirin of human venous prostacyclin synthesis and platelet thromboxane synthesis.
    Hanley SP; Bevan J; Cockbill SR; Heptinstall S
    Lancet; 1981 May; 1(8227):969-71. PubMed ID: 6112387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic fate of thromboxane A2 and prostacyclin.
    Roberts LJ; Brash AR; Oates JA
    Adv Prostaglandin Thromboxane Leukot Res; 1982; 10():211-25. PubMed ID: 6216783
    [No Abstract]   [Full Text] [Related]  

  • 15. Angiotensin-II-stimulated release of thromboxane A2 and prostacyclin (PGI2) in isolated, perfused kidneys of spontaneously hypertensive rats.
    Shibouta Y; Inada Y; Terashita Z; Nishikawa K; Kikuchi S; Shimamoto K
    Biochem Pharmacol; 1979 Dec; 28(24):3601-9. PubMed ID: 394747
    [No Abstract]   [Full Text] [Related]  

  • 16. Platelet-endothelial cell interactions. Metabolic maps of structures and actions of prostaglandins, prostacyclin, thromboxane and cyclic AMP.
    Nalbandian RM; Henry RL
    Semin Thromb Hemost; 1978; 5(2):87-111. PubMed ID: 216078
    [No Abstract]   [Full Text] [Related]  

  • 17. The key contribution of platelet and vascular arachidonic acid metabolism to the pathophysiology of atherothrombosis.
    Badimon L; Vilahur G; Rocca B; Patrono C
    Cardiovasc Res; 2021 Jul; 117(9):2001-2015. PubMed ID: 33484117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostacyclin (PGI2) and thromboxane A2 interaction in vivo. Regulation by aspirin and relationship with anti-thrombotic therapy.
    Korbut R; Moncada S
    Thromb Res; 1978 Sep; 13(3):489-500. PubMed ID: 369028
    [No Abstract]   [Full Text] [Related]  

  • 19. Biological properties of prostacyclin-thromboxane system.
    Blaskó G
    Ther Hung; 1984; 32(2):45-51. PubMed ID: 6443751
    [No Abstract]   [Full Text] [Related]  

  • 20. Aspirin, thromboxane, and prostacyclin in rats: A dilemma resolved?
    Livio M; Villa S; de Gaetano G
    Lancet; 1978 Jun; 1(8077):1307. PubMed ID: 78064
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.